OUtcome Following Tailored Education and Retraining: Studying Performance and Adherence in ChildrEn and Young People With Asthma: a Randomised Feasibility Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Asthma is a common disease which causes swelling in the airways, making it difficult to breathe. Asthma is common in children, affecting 1 in 11 children in the UK. Asthma is treated with inhalers which reduce the swelling. If inhalers are taken correctly they can help keep symptoms under control, allowing asthma sufferers to go about their day with less chance of having an asthma attack. Many patients have been found to not take their inhalers correctly and either under use (which leads to poor control of symptoms) or over use (which leads to potential side effects). Although asthma in most patients can be controlled with inhalers, not using inhalers correctly is one of the most common causes of poor control. This is common in children and young people (CYP) with all severities of asthma, resulting in high burden on the families and healthcare systems. The biggest challenge facing doctors and nurses helping CYP with asthma is finding a way to ensure that they take the medication. Whilst there are many studies looking into inhaler use, there are no large studies about how inhalers are used between clinic visits in CYP with asthma. The Smart Spacer is monitoring device which allows doctors to monitor when and how effectively inhalers are being used. This study wants to find out how well this device works, how well and how often CYP are using their inhalers, and if tailored education improves asthma control. To do this, participants in the study will be randomly selected to have tailored education or standard care education. The investigators are inviting 100 children and young people (CYP) aged 6-18 years who have asthma to join this study.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 6
Maximum Age: 18
Healthy Volunteers: f
View:

• Aged 6-18 years;

• Attending secondary care with a diagnosis of asthma;

• Willing and able to give fully informed consent, or, participants having an acceptable individual capable of giving consent on the participant's behalf (e.g. parent or guardian of a child under 16 years of age);

• Able to perform lung function and exhaled nitric oxide measurements;

• Take twice-daily preventer medication using a valved holding chamber (spacer device) i.e. inhaled corticosteroid with or without long-acting beta antagonist;

• Willing and able to comply with the study procedures.

Locations
Other Locations
United Kingdom
Robert James Bowler
RECRUITING
Stoke-on-trent
Contact Information
Primary
Robert Bowler
robert.bowler@uhnm.nhs.uk
01782
Backup
Keira Watts
Keira.Watts@uhnm.nhs.uk
01782
Time Frame
Start Date: 2022-09-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 100
Treatments
Active_comparator: Standard Care (Control) Group
Participants randomised to this group will receive usual care in terms of their education.
Experimental: Tailored Education Group
Participants randomised to this group will receive tailored education, which is additional to standard care.
Related Therapeutic Areas
Sponsors
Leads: University Hospitals of North Midlands NHS Trust

This content was sourced from clinicaltrials.gov